Karmanos Cancer Institute/BMT is a clinical research site located in Detroit, Michigan, United States 48201.
Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.
Karmanos Cancer Institute/BMT has participated in 7 clinical trials.
Therapeutic areas: Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma.
Sponsors: Medical College of Wisconsin, National Heart, Lung, and Blood Institute (NHLBI).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Detroit
Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Karmanos Cancer Institute/BMT has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Karmanos Cancer Institute/BMT has 7 clinical trials on record. Their work covers Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma.
Karmanos Cancer Institute/BMT has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.